The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis

American Journal of Gastroenterology

Volumn 94, Issue 6, 1999, Pages 1643-1649

  Shetty, Kirti ^a   Rybicki, Lisa ^a   Brzezinski, Aaron ^a   Carey, William D ^a   Lashner, Bret A ^a  

^a Center for Inflammatory Bowel Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; DYSPLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

ADULT; CHOLANGITIS, SCLEROSING; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0344603649     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01156.x     Document Type: Article

References (57)

1. Crohn B.B., Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci. 170:1925;220-225.
2. Bargen T.A. Chronic ulcerative colitis associated with malignant disease. Arch Surg. 17:1928;862-868.
3. Greenstein A.J., Sachar D.M., Smith H., et al. Cancer in universal and left-sided ulcerative colitis Factors determining risk . Gastroenterology. 77:1979;290-294.
4. Nugent F.W., Haggitt R.C., Colcher H., et al. Malignant potential of chronic ulcerative colitis. Gastroenterology. 76:1979;1-5.
5. Sugita A., Sachar D.B., Bodian C., et al. Colorectal cancer in ulcerative colitis Influence of anatomical extent and age at onset on cancer interval . Gut. 32:1991;167-169.
6. Chapman R.W.G., Marborgh B.A., Rhodes J.M., et al. Primary sclerosing cholangitis A review of its clinical features, cholangiography, and hepatic histology . Gut. 21:1980;870-877.
7. Sivak M.V. Jr, Farmer R.G., Lalli A.F. Sclerosing cholangitis Its increasing frequency of recognition and association with inflammatory bowel disease . J Clin Gastroenterol. 3:1981;261-266.
8. Lee Y.-M., Kaplan M.M. Primary sclerosing cholangitis. N Engl J Med. 332:1995;924-933.
9. Wewer V., Gluud C., Schlichting P., et al. Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease. Scand J Gastroenterol. 26:1991;97-102.
10. Olsson R., Danielsson A., Jarneroth G., et al. Prevalence of primary sclerosing cholangitis in ulcerative colitis. Gastroenterology. 100:1991;1319-1323.
11. Broome U., Lindberg G., Lofberg R. Primary sclerosing cholangitis in ulcerative colitis - A risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology. 102:1992;1877-1880.
12. D'Haens G.R., Lashner B.A., Hanauer S.B. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol. 88:1993;1174-1178.
13. Broome U., Lofberg R., Veress B., et al. Primary sclerosing cholangitis and ulcerative colitis Evidence for increased neoplastic potential . Hepatology. 22:1995;1404-1408.
14. Bansal P., Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol. 91:1996;44-48.
15. Brentnall T.A., Haggitt R.C., Rabinovitch P.S., et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 110:1996;331-338.
16. Nuako K.W., Ahlquist D.A., Sandborn W.J., et al. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis A case-control study . Cancer. 82:1998;822-826.
17. Marchesa P., Lashner B.A., Lavery I.C., et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 92:1997;1285-1288.
18. MacCarty R.L., LaRusso N.F., Wiesner R.H., et al. Primary sclerosing cholangitis Findings on cholangiography and pancreatography . Radiology. 149:1983;39-44.
19. Elias E., Summerfield J.A., Dick R., et al. Endoscopic retrograde cholangiopancreatography in the diagnosis of jaundice associated with ulcerative colitis. Gastroenterology. 67:1974;907-911.
20. Cello J.P. Acquired immunodeficiency syndrome cholangiopathy Spectrum of disease . Am J Med. 86:1989;539-546.
21. Riddell R.H., Goldman H., Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease Standardized classification with provisional clinical applications . Hum Pathol. 14:1983;931-968.
22. Astler V.B., Coller F.A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 139:1954;846-851.
23. Dukes C.E. The classification of cancer of the rectum. J Pathol. 35:1932;323-332.
24. Lashner B.A., Epstein S.S. Industrial risk factors for colorectal cancer. Int J Health Serv. 20:1990;459-483.
25. Loftus E.V. Jr, Sandborn W.J., Tremaine W.J., et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology. 110:1996;432-440.
26. Gurbuz A.K., Giardiello F.M., Bayless T.M. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum. 38:1995;37-41.
27. Timmermanns G., Heuschen U.A., Stern J., et al. Enhanced colorectal cancer risk in patients with ulcerative colitis associated PSC. Gastroenterology. 110:1996;A603.
28. Ahnen D.J., McHugh J.B.D., Arsenault L.L., et al. Does primary sclerosing cholangitis increase the risk of colon cancer in patients with chronic ulcerative colitis? Gastroenterology. 104:1993;A658.
29. Choi P.M., Nugent F.W., Rossi R.L. Relationship between colorectal neoplasia and primary sclerosing cholangitis in ulcerative colitis. Gastroenterology. 103:1992;1707-1708.
30. Wee A., Ludwig J. Pericholangitis in chronic ulcerative colitis Primary sclerosing cholangitis of the small bile ducts? Ann Intern Med. 102:1985;581-587.
31. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. N Engl J Med. 323:1990;1228-1233.
32. Ahnen D.J. Dysplasia and chronic ulcerative colitis. Rustgi A.K. Gastrointestinal cancers: Biology, diagnosis and therapy. 1995;399-411 Lippincott-Raven, Philadelphia.
33. Ekbom A., Helmick C.G., Zack M., et al. Survival and causes of death in patients with inflammatory bowel disease A population-based study . Gastroenterology. 103:1992;954-960.
34. Balan V., LaRusso N.F. Hepatobiliary disease in inflammatory bowel disease. Gastroenterol Clin North Am. 24:1995;647-667.
35. Rudolph G., Endele R., Senn M., et al. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology. 17:1993;1028-1032.
36. Jazrawi R.P., De Caestecker J.S., Goggin P.M., et al. Kinetics of hepatic bile acid handling in cholestatic liver disease Effect of ursodeoxycholic acid . Gastroenterology. 106:1994;134-142.
37. Nagengast F.M., Grubben M.J.A.L., van Munster I.P. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 31:1995;1067-1070.
38. Chomchai C., Bhadrachari N., Nigro N.D. The effect of bile on the induction of experimental intestinal tumors in rats. Dis Colon Rectum. 17:1974;310-312.
39. Narisawa T., Magadia N.E., Weisburger J.H., et al. Promoting effects of bile acids on colon carcinogenesis after intrarectal installation of MNNG in rats. J Natl Cancer Inst. 53:1974;1093-1097.
40. Hill M.J., Melville D.M., Lennard-Jones J.E., et al. Fecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet. 2:1987;185-186.
41. Summerton J., Flynn M., Cooke T., et al. Bile acid receptors in colorectal cancer. Br J Surg. 70:1983;549-551.
42. Zuccato E., Venturi M., Di Leo G., et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci. 38:1993;514-519.
43. Ekbom A., Yuen J., Adami H.-O., et al. Cholecystectomy and colorectal cancer. Gastroenterology. 105:1993;142-147.
44. Vernick L.J., Kuller L.H. Cholecystectomy and right-sided colon cancer An epidemiological study . Lancet. 2:1981;381-383.
45. McFarlane M.J., Welch K.E. Gallstones, cholecystectomy, and colorectal cancer. Am J Gastroenterol. 88:1993;1994-1999.
46. Giovannucci E., Colditz G.A., Stampfer M.J. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology. 105:1993;130-141.
47. Higashi H., Yanaga K., Marsh J.W., et al. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology. 11:1990;477-480.
48. Bleday R., Lee E., Jessurun J., et al. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum. 36:1993;908-912.
49. Loftus E.V. Jr, Aguilar H.I., Sandborn W.J., et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology. 27:1998;685-690.
50. Knechtle S.J., D'Alessandro A.M., Harms B.A., et al. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery. 118:1995;615-620.
51. Lindor K.D. Ursodiol for primary sclerosing cholangitis. N Engl J Med. 336:1997;691-695.
52. Lashner B.A., Heidenreich P.A., Su G.L., et al. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology. 97:1989;255-259.
53. Lashner B.A. Red blood cell folate is associated with cancer and dysplasia in ulcerative colitis. J Cancer Res Clin Oncol. 119:1993;549-554.
54. Lashner B.A., Provencher K.S., Seidner D.L., et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology. 112:1997;29-32.
55. Lashner B.A., Hanauer S.B., Silverstein M.D. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med. 108:1988;274-278.
56. Lashner B.A. Recommendations for colorectal cancer screening in ulcerative colitis A review of research from a single university-based surveillance program . Am J Gastroenterol. 87:1992;168-175.
57. Provenzale D., Kowdley K.V., Arora S., et al. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterol. 109:1995;1188-1196.